Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McClellan

Showing results (341-350 of 2,522) with videos related to

Pageof 253
Sort By:
Drugs|October 20, 1998
LevobupivacaineK J McClellan, C M Spencer
Clinical Chemistry|October 1, 1993
Nonlinearity of calcium measurement on the Kodak Ektachem at concentrations > 110 g/L (slide generations 18 and 19)A C McClellan, M G Scott
Drugs|November 26, 1998
Candesartan cilexetil. A review of its use in essential hypertensionK J McClellan, K L Goa
The Nebraska Medical Journal|September 1, 1996
Low thoracic fracture dislocation of the spineJ W McClellan, J W Brantigan
Journal of Molecular Biology|May 20, 1991
Structural alteration in alternating adenine-thymine sequences in positively supercoiled DNAJ A McClellan, D M Lilley
Journal of Pediatric Genetics|September 15, 2016
Beyond dissemination: A knowledge translation model to drive change in pediatric geneticsCheryl Greenberg, Kelly McClellan, Denise Avard
Journal of Child and Adolescent Psychopharmacology|May 6, 2017
Outcomes in Child PsychiatryJon M McClellan, John Scott Werry
The New England Journal of Medicine|October 19, 2007
Satisfaction guaranteed--"payment by results" for biologic agentsAlan M Garber, Mark B McClellan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2008
Breast cancer screening and dialysis: too much or too littleIdris Guessous, Valerie Duhn, William McClellan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1988
Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertensionW McClellan, E Tuttle, A Issa
Pageof 253

Showing results (341-350 of 2,522) with videos related to

Sort By:
Pageof 253
Drugs|October 20, 1998
LevobupivacaineK J McClellan, C M Spencer
Clinical Chemistry|October 1, 1993
Nonlinearity of calcium measurement on the Kodak Ektachem at concentrations > 110 g/L (slide generations 18 and 19)A C McClellan, M G Scott
Drugs|November 26, 1998
Candesartan cilexetil. A review of its use in essential hypertensionK J McClellan, K L Goa
The Nebraska Medical Journal|September 1, 1996
Low thoracic fracture dislocation of the spineJ W McClellan, J W Brantigan
Journal of Molecular Biology|May 20, 1991
Structural alteration in alternating adenine-thymine sequences in positively supercoiled DNAJ A McClellan, D M Lilley
Journal of Pediatric Genetics|September 15, 2016
Beyond dissemination: A knowledge translation model to drive change in pediatric geneticsCheryl Greenberg, Kelly McClellan, Denise Avard
Journal of Child and Adolescent Psychopharmacology|May 6, 2017
Outcomes in Child PsychiatryJon M McClellan, John Scott Werry
The New England Journal of Medicine|October 19, 2007
Satisfaction guaranteed--"payment by results" for biologic agentsAlan M Garber, Mark B McClellan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 31, 2008
Breast cancer screening and dialysis: too much or too littleIdris Guessous, Valerie Duhn, William McClellan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1988
Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertensionW McClellan, E Tuttle, A Issa
Pageof 253